A new study from the Autonomous University of Barcelona used computational tools to explore more than 100 proteins known as ...

A study shows that breastfeeding frequency and duration do not significantly alter the human milk microbiome, highlighting ...

A team of scientists led by the UAB has identified a new type of antimicrobial peptides (AMPs) found in human proteins that ...

Swiss pharma giant Roche says its new antibiotic zosurabalpin will progress to phase 3 testing. It’s the first drug in its ...

These mutated diseases defy the power of antibiotics. Are illnesses really mutating so fast that we can’t stay ahead of them?

Trends in AMR-related hospitalizations over the past decade were inconsistent and varied by causative pathogen, indicating the overall burden of AMR remains substantial.

Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a ...

GSK plans to submit to the US Food and Drug Administration (FDA) for regulatory approval of tebipenem HBr by the end of 2025.

Shared microbiomes across involved and uninvolved eyes may indicate that antibiotics are not always ideal in the treatment of chalazia.

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 ...